Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Pedro H C Franco"'
Autor:
Saulo Fehelberg Pinto Braga, Isabela Costa César, Renata Barbosa de Oliveira, Pedro H C Franco
Publikováno v:
Magnetic Resonance in Chemistry. 58:97-105
Quantitative nuclear magnetic resonance (qNMR) is an analytical technique that offers numerous advantages in pharmaceutical applications including minimum sample preparation and rapid data collection times with no need for response factor corrections
Autor:
Júlia Geraldi Vieira, Pedro H C Franco, Cristina Alves de Oliveira Ramos, Isabela Costa César, Renata Barbosa de Oliveira, Susana Johann
Publikováno v:
Biomedical Chromatography. 35
RI76 is a novel 2-thiazolylhydrazone compound with reported antifungal activity. In preclinical drug development, it is fundamental to know the impurity profile and to understand degradation mechanisms of the molecule. In our study, RI76 was subjecte
Autor:
Paulo H F, Carmo, Marliete C, Costa, Pedro H C, Franco, Anna C P, Lage, Cláudia E V, Rocha, Claudilene R, Chaves, André A G, Faraco, Luiz O, Ladeira, Jorge L López, Aguilar, Isabela C, César, Tatiane A, Paixão, Maria A, Resende-Stoianoff, Daniel A, Santos
Publikováno v:
Natural product research. 35(22)
The investigation of the effects of three essential oils (EOs) from
Autor:
Cláudia Emanuela Viana Rocha, Claudilene R. Chaves, Pedro H C Franco, Daniel Assis Santos, Paulo Henrique Fonseca Carmo, Jorge Luis Lopez Aguilar, Anna Carolina Pinheiro Lage, Tatiane A. Paixão, Maria Aparecida Resende-Stoianoff, Isabela Costa César, André Augusto Gomes Faraco, Marliete Carvalho Costa, Luiz Orlando Ladeira
The investigation of the effects of three essential oils (EOs) from Taxandria fragrans (FRA), Melaleuca alternifolia (TTO) and Boswellia serrata (IF), alone and combined with ketoconazole (KTZ), and their functionalised gold nanoparticles (AuNP) agai
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::793db5387bd76e1d73aa1f39a49baced
Autor:
Isabela Costa César, Gerson Antônio Pianetti, Vamshi Krishna Tippavajhala, Brenda Lee Simas Porto, Thiago de Oliveira Mendes, Marcone Augusto Leal de Oliveira, Paula Rocha Chellini, Pedro H C Franco
Publikováno v:
Vibrational Spectroscopy. 90:14-20
Tuberculosis is mainly treated by fixed dose combination therapy containing mainly rifampicin, isoniazid, pyrazinamide and ethambutol. The quality control of these drugs in these formulations is very important because of high incidence of resistance
Autor:
Pedro H C Franco, Felipe F. Rodrigues, Roger Ryuler Lisboa da Silva, Ivo S.F. Melo, Marília O. F. Goulart, Armando da Silva Cunha Júnior, Márcio M. Coelho, Andre Felippe de Almeida Xavier, Ianny Bandeira Rodrigues, Renata Barbosa de Oliveira, Renes R. Machado, Alysson Vinícius Braga, Anastacio Boane, Isabela Costa César, Mayara Rodrigues Brandão de Paiva, Gabriel Vitor de Lima Marques
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 133, Iss, Pp 110913-(2021)
Considering the many biological activities of nitric oxide (NO), some lines of research focused on the modulation of these activities through the provision of this mediator by designing and synthesizing compounds coupled with an NO donor group. Thus,
Autor:
Marcone Augusto Leal de Oliveira, Gerson Antônio Pianetti, Paula Rocha Chellini, Pedro H C Franco
Publikováno v:
Journal of AOAC International.
Tuberculosis is the second most deadly infectious disease, surpassed only by HIV/AIDS, and has resulted in over 1 billion deaths in the last 200 years. The World Health Organization estimates that in 2014, 9.6 million people were infected by this dis
Autor:
Fernando Henrique Andrade Nogueira, Paula Rocha Chellini, Gerson Antônio Pianetti, Eduardo Burgarelli Lages, Isabela Costa César, Pedro H C Franco
Publikováno v:
Journal of AOAC International. 98(5)
Tuberculosis treatment consists of a fixed dose combination of rifampicin (RIF), isoniazid (INH), pyrazinamide (PYZ), and ethambutol hydrochloride (EMB). The combined treatment using various drugs is necessary for patient curing, without recrudescenc